Your browser doesn't support javascript.
loading
A Dose-Escalating Pilot Study (NCT03017404) of Pegylated Liposomal Doxorubicin and Cyclophosphamide, Followed by Docetaxel Administration as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer.
Cheng, Meng; Song, Zhenchuan; Qi, Yixin; Wang, Xinle; Zhang, Lina; Shi, Jiajie; Wang, Mingxia.
Afiliação
  • Cheng M; Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China, waitforxl@163.com.
  • Song Z; Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Qi Y; Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Wang X; Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Zhang L; Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Shi J; Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Wang M; Office of Clinical Trials, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Oncol Res Treat ; 42(5): 269-274, 2019.
Article em En | MEDLINE | ID: mdl-30943501

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Doxorrubicina / Ciclofosfamida / Docetaxel Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Oncol Res Treat Ano de publicação: 2019 Tipo de documento: Article País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Doxorrubicina / Ciclofosfamida / Docetaxel Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Oncol Res Treat Ano de publicação: 2019 Tipo de documento: Article País de publicação: Suíça